BioPorto
BioPorto Logo
About BioPorto
BioPorto A/S is a Danish in-vitro diagnostics company specializing in the development and provision of biomarker-based tests and antibodies for clinicians and researchers worldwide. Its flagship product, the NGAL Test, enables early detection and risk assessment of acute kidney injury in critically ill patients. BioPorto also offers monoclonal antibodies, enzyme-linked immunosorbent assay kits, and rapid assay devices for custom lateral flow assays, supporting both clinical and preclinical research.
Address
Tuborg Havnevej 15, st., Ground Floor
Hellerup, 2900
Denmark
Year founded
1917
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Life Sciences Tools & Services
Report inaccurate data
Request an update to help us keep the brand up-to-date.
